Evidence map›Paper›PMID 28322550›Full record

ArticleAnalytical chemistry2017

Multiplex Substrate Profiling by Mass Spectrometry for Kinases as a Method for Revealing Quantitative Substrate Motifs.

Nicole O Meyer, Anthony J O'Donoghue, Ursula Schulze-Gahmen, Matthew Ravalin, Steven M Moss, Michael B Winter, Giselle M Knudsen, Charles S Craik

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Recent Advances in Protein Kinase Activity Analysis Based on Nanomaterials.International journal of molecular sciences · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Global substrate specificity profiling of post-translational modifying enzymes.Protein science : a publication of the Protein Society · 2018
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nicole O MeyerDepartment of Pharmaceutical Chemistry, University of California San Francisco , San Francisco, California 94158, United States.
Anthony J O'DonoghueDepartment of Pharmaceutical Chemistry, University of California San Francisco , San Francisco, California 94158, United States.
Ursula Schulze-GahmenDepartment of Molecular and Cell Biology, University of California Berkeley , Berkeley, California 94720, United States.
Matthew RavalinDepartment of Pharmaceutical Chemistry, University of California San Francisco , San Francisco, California 94158, United States.
Steven M MossDepartment of Pharmaceutical Chemistry, University of California San Francisco , San Francisco, California 94158, United States.
Michael B WinterDepartment of Pharmaceutical Chemistry, University of California San Francisco , San Francisco, California 94158, United States.
Giselle M KnudsenDepartment of Pharmaceutical Chemistry, University of California San Francisco , San Francisco, California 94158, United States.
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California San Francisco , San Francisco, California 94158, United States.ORCID 0000-0001-7704-9185
University of California, San Francisco · USUniversity of California, Berkeley · US

Funding

X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRANKEL, ALAN D · 2007 to 2018
$48.8M
Molecular and Cellular Mechanisms in CancerT32CA108462 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI · 2004 to 2024
$10.4M
RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
Profiling the Role of Protease Activity in Cancer ProgressionF32CA168150 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WINTER, MICHAEL B. · 2012 to 2014
$136k
Technology Development of Multiplex Substrate Profiling by Mass Spectrometry for Kinases and Application to the HIV-1 Tat - P-TEFb InteractionF31AI115889 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OLSON, NICOLE COOLEY · 2015 to 2016
$70k
NCI NIH HHS F32 CA168150NCI NIH HHS T32 CA108462NIAID NIH HHS F31 AI115889NIGMS NIH HHS P50 GM082250NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

The more than 500 protein kinases comprising the human kinome catalyze hundreds of thousands of phosphorylation events to regulate a diversity of cellular functions; however, the extended substrate specificity is still unknown for many of these kinases. We report here a method for quantitatively describing kinase substrate specificity using an unbiased peptide library-based approach with direct measurement of phosphorylation by tandem liquid chromatography-tandem mass spectrometry (LC-MS/MS) peptide sequencing (multiplex substrate profiling by mass spectrometry, MSP-MS). This method can be deployed with as low as 10 nM enzyme to determine activity against S/T/Y-containing peptides; additionally, label-free quantitation is used to ascertain catalytic efficiency values for individual peptide substrates in the multiplex assay. Using this approach we developed quantitative motifs for a selection of kinases from each branch of the kinome, with and without known substrates, highlighting the applicability of the method. The sensitivity of this approach is evidenced by its ability to detect phosphorylation events from nanogram quantities of immunoprecipitated material, which allows for wider applicability of this method. To increase the information content of the quantitative kinase motifs, a sublibrary approach was used to expand the testable sequence space within a peptide library of approximately 100 members for CDK1, CDK7, and CDK9. Kinetic analysis of the HIV-1 Tat (transactivator of transcription)-positive transcription elongation factor b (P-TEFb) interaction allowed for localization of the P-TEFb phosphorylation site as well as characterization of the stimulatory effect of Tat on P-TEFb catalytic efficiency.

Indexed as

Tandem Mass SpectrometryAmino Acid MotifsChromatography, High Pressure LiquidCyclin-Dependent Kinase 9HIV-1HumansKineticsPeptide LibraryPhosphopeptidesPhosphorylationPositive Transcriptional Elongation Factor BProtein KinasesSubstrate Specificitytat Gene Products, Human Immunodeficiency VirusCDK9 protein, humanCyclin-Dependent Kinase 9Peptide LibraryPhosphopeptidesPositive Transcriptional Elongation Factor BProtein Kinasestat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID28322550
PMCPMC5500290
OpenAlexW2602452000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.